Tweaking PET scans could sharpen lung cancer detection

NCT ID NCT02738398

First seen Jan 11, 2026 · Last updated Jun 20, 2026 · Updated 25 times

Summary

This study tested whether changing how FDG PET/CT scans are taken and processed can make them more accurate for staging lung cancer. Thirty adults with non-small cell lung cancer were enrolled. The goal was to see if better imaging could help doctors determine if cancer has spread to lymph nodes in the chest, without needing extra tests.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER (NSCLC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Abramson Cancer Center of the University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

FDG PET/CT scan (a type of imaging test)

What this could lead to

If successful, this could lead to more accurate lung cancer staging, helping doctors choose better treatments without needing extra invasive procedures.

What could go wrong

This is a small, completed study focused on imaging technique, not a new treatment. The results may not change current practice or apply to all patients.

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.